Scholar Rock Holding buy SVB Leerink LLC
Start price
15.09.25
/
50%
€27.80
Target price
15.09.26
€43.48
Performance (%)
33.81%
Price
17:32
€37.20
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Scholar Rock Holding has seen massive gains of 33.81%. This prediction currently runs until 15.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | -2.591% | -2.591% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $51.00 price target on the stock.
Ratings data for SRRK provided by MarketBeat